Cargando…

Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017

Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of...

Descripción completa

Detalles Bibliográficos
Autores principales: Heppe Montero, Marco, Gil-Prieto, Ruth, Walter, Stefan, Aleixandre Blanquer, Fernando, Gil De Miguel, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920124/
https://www.ncbi.nlm.nih.gov/pubmed/33653212
http://dx.doi.org/10.1080/21645515.2021.1883379
_version_ 1784669059603759104
author Heppe Montero, Marco
Gil-Prieto, Ruth
Walter, Stefan
Aleixandre Blanquer, Fernando
Gil De Miguel, Ángel
author_facet Heppe Montero, Marco
Gil-Prieto, Ruth
Walter, Stefan
Aleixandre Blanquer, Fernando
Gil De Miguel, Ángel
author_sort Heppe Montero, Marco
collection PubMed
description Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of severe bronchiolitis in Spain through population-based estimates of hospitalizations due to bronchiolitis in children up to 24 months old during a 6-year period (2012–2017). A total of 100,115 cases of bronchiolitis required hospitalization in Spain from 2012 to 2017. Most cases of bronchiolitis that required hospitalization were in infants under 3 months of age. The hospitalization rate for bronchiolitis for children under 1 year of age was 3,838.27 per 100,000 healthy children. During the 6-year study period, a total of 82 deaths due to bronchiolitis were reported among hospitalized infants. Among these deaths, more than 50% were in patients younger than 3 months of age. The annual average cost to the National Health Care System was €58 M, with a mean hospitalization cost of €3,512 per case.
format Online
Article
Text
id pubmed-8920124
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89201242022-03-15 Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel Hum Vaccin Immunother Novel Vaccines – Research Paper Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of severe bronchiolitis in Spain through population-based estimates of hospitalizations due to bronchiolitis in children up to 24 months old during a 6-year period (2012–2017). A total of 100,115 cases of bronchiolitis required hospitalization in Spain from 2012 to 2017. Most cases of bronchiolitis that required hospitalization were in infants under 3 months of age. The hospitalization rate for bronchiolitis for children under 1 year of age was 3,838.27 per 100,000 healthy children. During the 6-year study period, a total of 82 deaths due to bronchiolitis were reported among hospitalized infants. Among these deaths, more than 50% were in patients younger than 3 months of age. The annual average cost to the National Health Care System was €58 M, with a mean hospitalization cost of €3,512 per case. Taylor & Francis 2021-03-02 /pmc/articles/PMC8920124/ /pubmed/33653212 http://dx.doi.org/10.1080/21645515.2021.1883379 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Novel Vaccines – Research Paper
Heppe Montero, Marco
Gil-Prieto, Ruth
Walter, Stefan
Aleixandre Blanquer, Fernando
Gil De Miguel, Ángel
Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title_full Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title_fullStr Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title_full_unstemmed Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title_short Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
title_sort burden of severe bronchiolitis in children up to 2 years of age in spain from 2012 to 2017
topic Novel Vaccines – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920124/
https://www.ncbi.nlm.nih.gov/pubmed/33653212
http://dx.doi.org/10.1080/21645515.2021.1883379
work_keys_str_mv AT heppemonteromarco burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017
AT gilprietoruth burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017
AT walterstefan burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017
AT aleixandreblanquerfernando burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017
AT gildemiguelangel burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017